Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

NOVEMBER 15, 2021

Vice-President Michele Nakata, Supervisor of the Medical Cannabis Dispensary Licensing Program at the Hawaii Department of Health. At-large board member Andrew Turnage, Executive Director at the Georgia Access to Medical Cannabis Commission. Public Health and Data Monitoring. Lab Testing and Product Safety.

Compliance 98

Compliance Compliance Topical Programs 98

Cannabis Law Report

JUNE 15, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

JULY 22, 2022

As the only track-and-trace company to have successfully taken over a government contract from another vendor, Metrc will replace the State’s current partner and implement its robust track-and-trace platform to help facilitate the Rhode Island Medical Cannabis Program’s data collection and regulatory oversight. and now Rhode Island.

Data 52

Data Programs Access Compliance 52

Cannabis Law Report

AUGUST 10, 2021

–(BUSINESS WIRE)– PSI Labs , an Ann Arbor, Michigan-based ISO 17025 accredited Safety Compliance Facility that provides essential cannabis testing services, today announced its expansion into Southern California with the acquisition of pH Solutions, LLC. PSI Labs is also a founding member of the Leafly Certified Labs Program.

Research and Development 105

Research and Development Compliance Compliance Safety 105

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. These doses are produced under Good Agricultural and Collection Practices and tested for potency and impurities to support patient safety and practitioner confidence.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

The Joint Blog

JUNE 8, 2020

We continue to explore and report on new cannabis related university and certification programs that are popping up around the world to help meet the demand of employment for the sector. Interpret data to assess crop health and quality and adapt to growth conditions/pest management strategies. And much more!

Programs 32

Programs Research and Development Environment Packaging 32

MMJ Recs

MARCH 16, 2024

Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols. Changes in regulations can have ripple effects throughout the industry, impacting supply chains, investment strategies, and consumer access to medical cannabis products.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. The industry also encourages the development of novel pharmaceuticals and treatments, creating opportunities for Maryland residents to access cutting-edge healthcare options.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

SEPTEMBER 18, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 52

Compliance Compliance Seed-To-Sale Data 52

Cannabis Law Report

AUGUST 16, 2022

Seamless data tracking helps operators optimize inventory control, accurately report sales data, and improve cultivation management. As Alabama works to solidify its medical cannabis program, we are thrilled to have the opportunity to spearhead the state’s first-ever track-and-trace program,” said Michael Johnson, CEO at Metrc.

Seed-To-Sale 52

Seed-To-Sale Supply Chain Data Patients 52

Cannabis Law Report

JUNE 9, 2022

11:00-12:00 PM: Interstate Commerce: Impacts on markets, licensing, and consumer safety. Steph Sherer, Founder and President, Americans for Safe Access. Panelists: David Crawford, Senior Program Manager, Code for America. Katie Mueller, Senior Program Manager, National Safety Council. Cannabis Council.

Policy 52

Policy Safety Seed-To-Sale Data 52

Cannabis Law Report

APRIL 5, 2022

Metrc will help facilitate Mississippi’s medical cannabis program’s data collection and regulatory oversight through its robust track-and-trace platform. State regulators can also conveniently access this same information, which will be essential in creating a safe and secure marketplace for both patients and providers. “We

Safety 52

Safety Patients Dispensary Compliance 52

Cannabis Law Report

JUNE 9, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 66

Compliance Compliance Seed-To-Sale Data 66

SpeedWeed

JULY 25, 2021

At long last the Georgia Access to Medical Marijuana Commission chose six companies that will be allowed to grow, manufacture and sell medical marijuana oil capped at 5% THC. Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Your submission has been received!

Media 52

Media Data Dispensary Access 52

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. Four in five Americans (80% ) voiced their support for a program that would make it easier to detect legal vs. illegal cannabis products.

Safety 52

Safety Research and Development Compliance Compliance 52

Veriheal

AUGUST 31, 2022

Harocopos and his team explain that OPCs, also known as supervised/safe consumption sites, are considered to be “health care facilities that aim to improve individual and community health, increase public safety and reduce the consequences of drug use, including overdose deaths, public drug use and syringe litter.” The Research Letter.

Consumption 104

Consumption Data Treatment Collective 104

SpeedWeed

MARCH 26, 2021

A study of data from across the country has found no evidence that the legalization of medical cannabis and the establishment of dispensaries encourages marijuana use by young people. Lower Cannabis Use Among 9th Graders.

Legalization 52

Legalization Data Marijuana Collective 52

Cannabis Law Report

JULY 13, 2022

The Department took steps this year to deliver on the promise of consolidation, establishing regulatory reforms that streamline requirements for cannabis licensees, unifying department operations to more efficiently support the entire supply chain, centralizing complaint reporting, and enhancing access to public resources and information.

Compliance 52

Compliance Compliance Supply Chain Environment 52

SpeedWeed

AUGUST 12, 2021

After concluding that CBD products are excluded from being listed under the definition of a dietary supplement, Cara Welch, Acting Director of the Office of Dietary Supplement Programs elaborated on the issue. The FDA letter asserts that a FSHE cannot be used in dietary supplements because it is precluded and expresses safety concerns.

Extraction 52

Extraction Hemp Safety Data 52

Veriheal

AUGUST 3, 2021

This legislation provides important updates to our state’s medical [cannabis] program to ensure that patients have improved access to medication.”. That change would have marked a distinct expansion of Pennsylvania’s existing medical cannabis program, which only allows patients to procure their medicine from licensed dispensaries.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

NOVEMBER 6, 2019

The agreement will give hemp-derived product companies access to the broad resources of each organization to conduct clinical and/or observational research related to hemp-derived products and their effects on humans and animals. About ValidCare. For more information, visit www.validcare.com or call 844-825-4322.

Hemp 45

Hemp Data Access Education 45

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. The bill allocates $2 million for the grant program. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD.

Legislation 97

Legislation Treatment Therapy Conditions 97

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Entrepreneurs and businesses leverage this data to navigate the competitive landscape, ensuring they meet market demands.

Marijuana 52

Marijuana Dispensary Supply Chain Research and Development 52

Cannabis Law Report

NOVEMBER 6, 2019

Developing our Responsible Vendor Training Program , which will support licensee compliance and enhance the safety of customers and employees of cannabis businesses in the Commonwealth.

Research and Development 45

Research and Development Programs Education Compliance 45

Cannabis Law Report

SEPTEMBER 29, 2021

Medical students who register for the program will have access to eight hours of medical cannabis education, including the latest scientific research on the endocannabinoid system and the known effects of cannabis on the human body. TCI offers cannabis medical education in both English and Spanish. About Dr. Jan Roberts ?

Cannabinoids 52

Cannabinoids Education Patients Safety 52

MassRoots

AUGUST 4, 2020

Cannabis businesses deserve the same access to banking and insurance services as any other legitimate business. We need SAFE Banking to ensure that BIPOC (Black, Indigenous, People of Color) owned businesses, especially women, have equitable access to funding and for the safety of our employees and our communities.

Banking 52

Banking Access Business Programs 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

SpeedWeed

APRIL 29, 2021

OSCC provides cannabis products to compassion centers operating in Portsmouth, Providence and Warwick that serve more than 18,000 cannabis patients in Rhode Island’s medical program. increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission. billion overall.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

SEPTEMBER 12, 2022

The Company is working to supply various upcoming phase 1 & 2 clinical trials to build out the required human safety data in healthy Canadians, and eventually patients suffering from depression, anxiety, and PTSD. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Finally, the DOT would be directed to collect data on cannabis-impaired driving to enable the development of an impairment standard for driving under the influence of cannabis.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

JULY 28, 2021

MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105